Key stats
About GLOBAL X GENOMICSBIOTECH
Expense ratio
0.50%
Home page
Inception date
Nov 2, 2021
ISIN
IE00BM8R0N95
The Funds investment objective is to generate returns that closely correspond, before fees and expenses, generally to the price and yield performance of the Solactive Genomics v2 Index
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.83%
Health Technology99.15%
Health Services0.68%
Bonds, Cash & Other0.17%
Cash0.16%
Miscellaneous0.00%
Stock breakdown by region
North America97.08%
Asia2.92%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history